Key result
AHN@C nanocomposite adjuvant efficiently induces humoral and cellular immune responses in mice.
Supports advancement of AHN@C to larger animal models; leaves open translation as a human vaccine adjuvant.
Foot-and-mouth disease (FMD) is a viral infectious disease of artiodactyls that threatens the global livestock economy and public health security. Vaccination is employed to prevent the occurrence of infectious diseases, and adjuvants play a key role in vaccine preparation. Commercially available FMD vaccines mainly use oil-emulsion adjuvants that induce a humoral immune response in the body. Based on the acrylate hydrogel adjuvant (AHN) with sustained-release properties, this study introduced CpG, Poly I:C, and QS-21 immunostimulants to create an prepare immunostimulant-integrated acrylate nanocomposite adjuvant (AHN@X) combining excellent antigen delivery capability and immune response direction regulation for use in FMD vaccines. AHN@X has a particle size of less than 100 nm, and it exhibits good storage stability at 4 °C. The FMD vaccines prepared with AHN@X nanocomposite adjuvant were immunized by intramuscular injection in BALB/c mice. The results showed that it could efficiently induce specific IgG, IgG1 and IgG2a antibody titers and activate B cells and T cells. Moreover, AHN@C stimulated splenocytes to secrete cytokines IFN-γ and IL-4 at the highest concentrations, 58.34 pg/mL and 32.24 pg/mL respectively. Additionally, the AHN@C nanocomposite adjuvant promoted the strongest endocytosis of antigens by macrophages, and it efficiently induced humoral immune responses and cellular immune responses. Overall, the clinical protective efficacy of AHN@C against FMDV is worth subsequent validation in target livestock animals.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2026) studied Foot-and-mouth disease (FMD). AHN@X nanocomposite adjuvant (AHN@C) was evaluated on Humoral and cellular immune responses (including IFN-γ and IL-4 secretion). The AHN@C nanocomposite adjuvant efficiently induced humoral and cellular immune responses in BALB/c mice, stimulating splenocytes to secrete IFN-γ (58.34 pg/mL) and IL-4 (32.24 pg/mL).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: